Pathfinder Medical – a medical device company improving outcomes for vascular procedures – has secured an GBP8.5 million funding round led by investors BGF and Parkwalk, along with a number of industry insiders, and with support from existing investor Deepbridge Capital.
Pathfinder was co-founded in 2014 by Robert Dickinson and CEO Sorin Popa following the latter’s research at Imperial College London into the use of electric fields for guidance in medical device procedures.
Following the investment, Chas Taylor will be joining the board as Chairman and Stefano Ciampolini as Non-Executive Director. Taylor is serial entrepreneur in the medical device industry, having founded and exited three companies in the vascular space (MedNova, Novate, Veryan). Ciampolini is a serial healthcare entrepreneur, having founded and successfully exited several companies in the dialysis and renal care sector including UK dialysis company Renal Services.
